核黄素与健康研究进展

罗贤懋; 杨欢; 王晓坤; 范金虎; 乔友林

doi:10.16689/j.cnki.cn11-9349/r.2026.02.004

PDF(1559 KB)

肿瘤代谢与营养电子杂志 ›› 2026, Vol. 13 ›› Issue (2) : 195-202. DOI: 10.16689/j.cnki.cn11-9349/r.2026.02.004

专家论坛

核黄素与健康研究进展

罗贤懋, 杨欢, 王晓坤, 范金虎, 乔友林

作者信息 +

Research progress of riboflavin and health

Luo Xianmao,Yang Huan,Wang Xiaokun,Fan Jinhu,Qiao Youlin

Author information +

文章历史 +

摘要

近年来,有关核黄素与健康的研究逐渐增多,国内针对核黄素与恶性肿瘤等疾病预防的研究也取得了较大突破。本文初步汇集和整理了核黄素与恶性肿瘤、心脑血管疾病、神经系统退行性病变、遗传性代谢疾病、贫血和白内障等疾病防治的有关资料,以期为卫生政策制定提供系统参考,并延续我国核黄素强化碘盐干预试验所取得的进展和成果。此外,为落实《“健康中国2030”规划纲要》中提出的“对重点区域、重点人群实施营养干预,重点解决微量营养素缺乏等问题”的要求,建议可恢复食管癌高发区核黄素强化碘盐的生产和供应,不仅对高发区居民预防肿瘤等常见病会产生社会效益,对改善我国居民长期核黄素摄入不足的现状也会产生积极影响。

Abstract

Research about riboflavin and health is gradually increasing in recent years, domestic research on riboflavin and disease prevention such as cancer has also made major breakthroughs. This paper reviews relevant information about riboflavin and cancer prevention, cardiovascular and cerebrovascular diseases, degenerative disease of the nervous system, the inherited metabolic diseases, anemia, and cataract, to provide systematic references for health policy formulation, as well as to continue the process and achievement of riboflavin-fortified iodized salt nutrition intervention trial in China. Besides, to implement the proposal of “Implement nutrition interventions in key regions and populations and focus on solving problems such as micronutrient deficiencies” in “Healthy China 2030” blueprint, it is recommended to resume the production and supply of riboflavin-fortified iodized salt in the high-incidence area of esophageal cancer, which will not only have social benefits for residents in high-incidence areas to prevent common diseases such as cancer, but also have a positive effect on improving the current status of long-term insufficient intake of riboflavin among Chinese residents.

导出引用

罗贤懋, 杨欢, 王晓坤, 范金虎, 乔友林. 核黄素与健康研究进展[J]. 肿瘤代谢与营养电子杂志. 2026, 13(2): 195-202 https://doi.org/10.16689/j.cnki.cn11-9349/r.2026.02.004

Luo Xianmao,Yang Huan,Wang Xiaokun,Fan Jinhu,Qiao Youlin. Research progress of riboflavin and health[J]. Electronic Journal of Metabolism and Nutrition of Cancer. 2026, 13(2): 195-202 https://doi.org/10.16689/j.cnki.cn11-9349/r.2026.02.004

参考文献

[1] SUWANNASOM N, KAO I, PRU A, et al. Riboflavin: the health benefits of a forgotten natural vitamin[J]. Int J Mol Sci,2020,21(3):950.
[2] THAKUR K, TOMAR S K, SINGH A K, et al. Riboflavin and health: A review of recent human research[J]. Crit Rev Food Sci Nutr,2017,57(17):3650-3660.
[3] 中国营养学会. 中国居民膳食营养素参考摄入量(2023 版)[M]. 北京:人民卫生出版社,2023.
[4] 翟凤英,何宇纳,王志宏,等. 中国城乡居民膳食营养素摄入状况及变化趋势 [C] // 中国营养学会妇幼营养分会,国际生命科学会中国办事处. 补充营养素和饮奶对人体有害吗媒体论坛会 / 学术研讨会会议资料. 北京:中国疾病预防控制中心营养与食品安全所,2007: 5-9.
[5] 郭齐雅,赵丽云,何宇纳,等. 2010—2012 年中国居民营养素摄入状况 [J]. 中华预防医学杂志,2017, 51 (6): 519-522.
[6] 于冬梅,赵丽云,琚腊红,等. 2015—2017 年中国居民能量和主要营养素的摄入状况 [J]. 中国食物与营养,2021, 27 (4): 5-10.
[7] BORG ST, VERLAAN S, HEMSWORTH J, et al. Micronutrient intakes and potential inadequacies of community-dwelling older adults: a systematic review[J]. Br J Nutr,2015,113(8):1195-1206.
[8] 郭齐雅,于冬梅,俞丹,等. 1959、1982、1992、2002 及 2010—2013 年中国居民营养与健康状况调查 / 监测比较分析 [J]. 卫生研究,2016, 45 (4): 542-547.
[9] 金大勋,陈春明,葛可佑,等. 1982 年全国营养调查 [Z]. 北京:中国预防医学科学院营养与食品卫生研究所,1984.
[10] 林海,翟凤英,薛禾生,等. 1992 年全国营养调查人口年龄资料的三项指数检验 [J]. 卫生研究,1996 (S1): 57-61.
[11] 杨月欣. 中国食物成分表标准版[M]. 6版. 北京:北京大学医学出版社,2018.
[12] YONEZAWA A, INUI K I. Novel riboflavin transporter family RFVT/SLC52: Identification, nomenclature, functional characterization and genetic diseases of RFVT/SLC52[J]. Mol Aspects Med,2013,34(2/3):693-701.
[13] 罗贤懋,林培中,刘雨菁,等. 核黄素预防恶性肿瘤的研究进展 [J]. 癌症进展,2020, 18 (4): 325-330.
[14] 孙秀娣,陈君泽,范金虎,等. 盐亭县核黄素强化盐干预试验人群肿瘤发病情况 [J]. 中国肿瘤,2005, 14 (6): 357-361.
[15] HE Y, YE L, SHAN B, et al. Effect of riboflavin-fortified salt nutrition intervention on esophageal squamous cell carcinoma in a high incidence area, China[J]. Asian Pac J Cancer Prev,2009,10(4):619-622.
[16] 许虹,李烨,宋国慧,等. 核黄素强化盐预防高发区食管癌效果研究 [J]. 现代预防医学,2013, 40 (5): 936-938.
[17] 黎钧耀,布洛特,李冰,等. 中国林县居民癌症和其它常见病营养预防试验效果初步报告 [J]. 中华肿瘤杂志,1993, 15 (3): 165-181.
[18] WANG S M, TAYLOR P R, FAN J H, et al. Effects of nutrition intervention on total and cancer mortality: 25-year post-trial follow-up of the 5.25-year Linxian nutrition intervention trial[J]. J Natl Cancer Inst,2018,110(11):1229-1238.
[19] REN J, MURPHY G, FAN J, et al. Prospective study of serum B vitamins levels and oesophageal and gastric cancers in China[J]. Sci Rep,2016,6:35281.
[20] LI S S, XU Y W, WU J Y, et al. Plasma riboflavin level is associated with risk, relapse, and survival of esophageal squamous cell carcinoma[J]. Nutr Cancer,2017,69(1):21-28.
[21] WANG L D, ZHOU F Y, LI X M, et al. Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54[J]. Nat Genet,2010,42(9):759-763.
[22] 纪爱芳,魏武,杨建洲,等. 核黄素转运蛋白 C20orf54 基因 rs3746804 位点单核苷酸多态性与食管鳞癌遗传易感性的关系 [J]. 中华内科杂志,2012, 51 (12): 982-986.
[23] LU Y T, GUNATHILAKE M, LEE J, et al. Riboflavin intake, MTRR genetic polymorphism (rs1532268) and gastric cancer risk in a Korean population: a case-control study[J]. Br J Nutr,2022,127(7):1026-1033.
[24] LEE S M, SEOL A, CHO H W, et al. Optimal dietary intake of riboflavin associated with lower risk of cervical cancer in Korea: Korean National Health and Nutrition Examination Survey 2010-2021[J]. Life (Basel),2024,14(4):529.
[25] WALD D S, LAW M, MORRIS J K. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis[J]. BMJ,2002,325:1202.
[26] 赵唱,贺欣. MTHFR C677T 基因多态性与同型半胱氨酸及冠心病的关系 [J]. 中国当代医药,2020, 27 (26): 4-7.
[27] 陈甲,和儒林,朗莹,等. 中国人群 MTHFR 基因 C677T 多态性与青中年缺血性脑卒中相关性的 Meta 分析 [J]. 中国循证医学杂志,2014, 14 (4): 435-442.
[28] 王阳,陈建立,陈俊卯,等. 中国人群 MTHFR C677T 基因多态性与静脉血栓症相关性的 Meta 分析 [J]. 实用药物与临床,2017, 20 (9): 1004-1008.
[29] MCNULTY H, DOWEY L R C, STRAIN J J, et al. Riboflavin lowers homocysteine in individuals homozygous for the MTHFR 677C→T polymorphism[J]. Circulation,2006,113(1):74-80.
[30] CAO X, WANG X, TIAN Y, et al. Trends and sociodemographic patterns in hypertension prevalence and treatment in China[J]. Med,2025,6(11):100808.
[31] LIU M Y, ZHOU C, ZHANG Z X, et al. Inverse association between riboflavin intake and new-onset hypertension: a nationwide cohort study in China[J]. Hypertension,2020,76(6):1709-1716.
[32] YANG K M, JIA J, MAO L N, et al. Methylenetetrahydrofolate reductase C677T gene polymorphism and essential hypertension: A meta-analysis of 10,415 subjects[J]. Biomed Rep,2014,2(5):699-708.
[33] HORIGAN G, MCNULTY H, WARD M, et al. Riboflavin lowers blood pressure in cardiovascular disease patients homozygous for the 677C>T polymorphism in MTHFR[J]. J Hypertens,2010,28(3):478-486.
[34] WILSON C P, MCNULTY H, WARD M, et al. Blood pressure in treated hypertensive individuals with the MTHFR 677TT genotype is responsive to intervention with riboflavin: findings of a targeted randomized trial[J]. Hypertension,2013,61(6):1302-1308.
[35] WILSON D M 3RD, COOKSON M R, VAN DEN BOSCH L, et al. Hallmarks of neurodegenerative diseases[J]. Cell,2023,186(4):693-714.
[36] UDHAYABANU T, MANOLE A, RAJESHWARI M, et al. Riboflavin Responsive Mitochondrial Dysfunction in Neurodegenerative Diseases[J]. J Clin Med,2017,6(6):52.
[37] NAGHASHPOUR M, JAFARIRAD S, AMANI R, et al. Update on riboflavin and multiple sclerosis: a systematic review[J]. Basic Med Sci,2017,20:958-966.
[38] COIMBRA C G, JUNQUEIRA V B C. High doses of riboflavin and the elimination of dietary red meat promote the recovery of some motor functions in Parkinson’s disease patients[J]. Braz J Med Biol Res,2003,36(10):1409-1417.
[39] KAMAT P K, VACEK J C, KALANI A, et al. Homocysteine induced cerebrovascular dysfunction: a Link to Alzheimer’s disease etiology[J]. Open Neurol J,2015,9:9-14.
[40] ZHOU L. Association of vitamin B2 intake with cognitive performance in older adults: a cross-sectional study[J]. J Transl Med,2023,21(1):870.
[41] JI K, SUN M, LI L, et al. Association between vitamin B2 intake and cognitive performance among older adults: a cross-sectional study from NHANES[J]. Sci Rep,2024,14(1):21930.
[42] DU C, ZHANG M, ZHANG X, et al. Association of Anaemia and Anthropometric Indices among Chinese adults: based on the sixth china chronic disease and risk factor surveillance[J]. Nutrients,2025,17(19):3045.
[43] POWERS H J, WEAVER L T, AUSTIN S, et al. Riboflavin deficiency in the rat: effects on iron utilization and loss[J]. Br J Nutr,1991,65(4):487-496.
[44] POWERS H J, HILL M H, MUSHTAQ S, et al. Correcting a marginal riboflavin deficiency improves hematologic status in young women in the United Kingdom[J]. Am J Clin Nutr,2011,93(6):1274-1284.
[45] SHI Z, ZHEN S, WITTERT G A, et al. Adequate riboflavin intake and anemia risk in a chinese population: five-year follow up of the Jiangsu nutrition study[J]. PLoS One, 2014, 9(2): e88862.
[46] MOSEGAARD S, DIPACE G, BROSS P, et al. Riboflavin Deficiency—Implications for General Human Health and Inborn Errors of Metabolism[J]. Int J Mol Sci,2020,21(11):3847.
[47] 操基清,张成,李亚勤,等. 核黄素反应性脂质沉积性肌病临床特征与基因突变分析:两家系三例报告并文献复习 [J]. 中国现代神经疾病杂志,2014, 14 (6): 479-484.
[48] 孙毅明,操基清,利婧,等. 核黄素反应性多酰基辅酶 A 脱氢酶缺乏症的临床表现与基因突变多样性 [J]. 中国现代神经疾病杂志,2020, 20 (6): 534-540.
[49] 王韵,赵丹华,洪道俊,等. 核黄素反应性脂质沉积性肌病 20 个家系的电子转移黄素蛋白脱氢酶基因存在热点突变 [J]. 中华神经科杂志,2011, 44 (5): 309-313.
[50] FOLEY A R, MENEZES M P, PANDRAUD A, et al. Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2[J]. Brain,2014,137(Pt 1):44-56.
[51] SOYUYUCE O G, AKSOY E A, YAPICI Z. A case report of sudden-onset auditory neuropathy spectrum disorder associated with Brown-Vialetto-Van Laere syndrome (riboflavin transporter deficiency)[J]. Int J Audiol, 2022,61(3):258-264.
[52] LESKE M C, WU S Y, HYMAN L, et al. Biochemical factors in the lens opacities: Case-control study. The Lens Opacities Case-Control Study Group[J]. Arch Ophthalmol,1995,113(9):1113-1119.
[53] SPERDUTO R D, HU T S, MILTON R C, et al. The Linxian cataract studies: Two nutrition intervention trials[J]. Arch Ophthalmol,1993,111(9):1246-1253.
[54] NAMAZI N, HESHMATI J, TARIGHAT-ESFANJANI A. Supplement with riboflavin (Vitamin B2) for migraine prophylaxis in adults and children: A review[J]. Int J Vitam Nutr Res,2015,85(1/2):79-87.
[55] CONDO M, POSAR A, ARBIZZANI A, et al. Riboflavin prophylaxis in pediatric and adolescent migraine[J]. J Headache Pain,2009,10(5):361-365.
[56] AMINI S, HEIDARI Z, CLARK C C T, et al. The effect of riboflavin on the mean attack frequency, severity, and duration of migraine headaches: A systematic review and dose-response meta-analysis of clinical trials[J]. J Res Med Sci,2026,31:1.
[57] CHOCANO-BEDOYA P O, MANSON J E, HANKINSON S E, et al. Dietary B vitamin intake and incident premenstrual syndrome[J]. Am J Clin Nutr,2011,93(5):1080-1086.
[58] BERTONE-JOHNSON E R, WHITCOMB B W, RICH-EDWARDS J W, et al. Premenstrual syndrome and subsequent risk of hypertension in a prospective study[J]. Am J Epidemiol,2015,182(12):1000-1009.
[59] ILESANMI-OYELERE B L, BROUGH L, COAD J, et al. The relationship between nutrient patterns and bone mineral density in postmenopausal women[J]. Nutrients,2019,11(6):1262.
[60] SHONO N, KUGINO K, YOSHIDA S, et al. Bone mineral density by ultrasonic measurement in pre-and postmenopausal women: relationship with sex hormones and nutritional states[J]. Nippon Eiseigaku Zasshi,1997,51(4):755-762.
[61] NETO A H C, YANO C L, PAREDES-GAMERO E J, et al. Riboflavin and photoproducts in MC3T3E1 Differentiation[J]. Toxicol In Vitro,2010,24(7):1911-1919.
[62] 张彩凤,向平,秧茂盛,等. 克罗恩病 1 例报告并文献复习 [J]. 中国当代医药,2019, 26 (33): 198-200, 204.
[63] VON MARTELS J Z H, BOURGONJE A R, KLAASSEN M A Y, et al. Riboflavin supplementation in patients with Crohn's disease[J]. J Crohns Colitis,2020,14(5):595-607.
[64] HOFFMAN M D, VALENTINO T R, STUEMPFLE K J, et al. A Placebo-Controlled Trial of Riboflavin for Enhancement of Ultramarathon Recovery[J]. Sports Med Open,2017,3(1):14.
[65] 郑素芳. 膳食、营养与食管癌 [M] // 中国癌症研究进展. 昆明:云南科技出版社,1993: 69-75.
[66] 郑素芳,刘新伏,李辉,等. 食管癌高发区林县人群维生素的营养状况 [J]. 中华肿瘤杂志,1985 (增刊): 49-52.
[67] 郑素芳,李辉,宋林华,等. [J]. 中华肿瘤杂志,1985, 7 (增刊): 58-59.
[68] 林培中. 核黄素缺乏和超量维生素 C 对大鼠食管和肝脏癌变的影响 [J]. 中华肿瘤杂志,1985, 7 (3): 171-174.
[69] 乔长虹,郑素芳. 核黄素缺乏促进亚硝胺致癌的研究 — 对大鼠肝脏谷胱甘肽含量的影响 [J]. 中华肿瘤杂志,1989, 11 (3): 92-93.
[70] 沈琼,王东煜,项芸岩,等. 复合核黄素阻断治疗食管癌前增生研究报告 [J]. 中国肿瘤临床,1994, 21 (4): 250-251.
[71] 丁镇伟,高峰,林培中. 食管癌前病变阻断性治疗的远期效果 [J]. 中华肿瘤杂志,1999, 21 (4): 275-277.
[72] 郑素芳.核黄素与癌[J].中国肿瘤,1994,(6):11-13.
[73] MUOZ N, HAYASHI M, BANG L J, et al. Effect of riboflavin, retinol, and zinc on micronuclei of buccal mucosa and of esophagus: a randomized double-blind intervention study in China[J]. J Natl Cancer Inst,1987,79(4):687-691.
[74] 罗贤懋,崔剑锋. 核黄素与癌症的预防 [J]. 肿瘤防治研究,2006, 33 (7): 543-544.
[75] 冯爽,于晓东,李变云,等. 2008—2013 年河南省林州市食管癌发病趋势分析 [J]. 肿瘤预防与治疗,2018, 31 (5): 347-351.
[76] 宋国慧,李东方,贺宇彤,等. 中国食管癌高发区磁县上消化道癌两个时期发病率的比较与分析 [J]. 中国肿瘤临床,2017, 44 (19): 979-987.
[77] PETERSEN P E, LENNON M A. Effective use of fluorides for the prevention of dental caries in the 21st century: the WHO approach[J]. Community Dent Oral Epidemiol,2004,32(5):319-321.
[78] MARTHALER T M. Salt fluoridation and oral health[J]. Acta Med Acad,2013,42(2):140-155.
[79] ZHAI F, WANG H, DU S, et al. Lifespan nutrition and changing socio-economic conditions in China[J]. Asia Pac J Clin Nutr,2007,16(Suppl 1):374-382.
[80] 郑荣寿,孙可欣,张思维,等. 2015 年中国恶性肿瘤流行情况分析 [J]. 中华肿瘤杂志,2019, 41 (1): 19-28.